Preclinical studies have shown that defects in IFNGR1 (IFN-γ receptors) and JAK1/2 genes cause tumor cells to be unresponsive to IFN- γ, which allows tumor cells to grow in the presence of IFN- γ [209]. Here, IFNGR1 is linked to neoplasm.